Tuesday 6 February 2018

Automotivepolymer composites market Expected to reach USD 11.6 billion by 2025 : Grand View Research, Inc.

The global automotivepolymer composites market size is expected to reach USD 11.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.8% during the forecast period. Polymer, metal, and ceramic matrix composites are key composites used in the automotive industry.
The use of polymer matrix composites on a large scale in the manufacturing of exterior components such as rear windshield glazing, fender, panoramic roof modules, wheel covers, headlight lenses, headlight housings, bumper, and front grille is expected to drive the market over the forecast period. The automotive industry is witnessing challenges in aligning production or assembly processes with enhanced material properties and innovative product design, especially for large-volume production facilities. Although aluminum and steel are mostly used in lightweight vehicles, high-performance FRP composites can potentially outperform both aluminum and steel.
Private collaborations between companies in automotive and chemical industries, such as Toray and Daimler, SGL and BMW, SGL and Volkswagen, and Toho Tenax and General Motors, have substantially helped in the allocation of resources in the automotive polymer composites industry. For instance, in 2014, BMW-SGL announced an investment of approximately USD 200 million to triple the production capacity of its CFRP plant located in Moses Lake, Washington, U.S.
Product innovation is one of the key challenges faced by companies operating in the market. Manufacturers are aiming at reducing costs and increasing efficiency of products. Implementation of passenger safety laws such as the Federal Motor Vehicle Safety Standards (FMVSS) is anticipated to drive the automotive polymer composites market over the forecast period. 
Full research report on Automotive Polymer Composites Market analysis: https://www.grandviewresearch.com/industry-analysis/automotive-polymer-composites-market

Further key findings from the study suggest:
·         Demand for automotive polymer composites from electric vehicles is expected to rise at an estimated CAGR of 7.0% from 2017 to 2025 due to increasing focus on using lightweight materials
·         Vinyl ester-based polymer composites are expected to witness the highest growth over the forecast period. These composites are used in mainstream automotive applications such as sunroof, radiator assembly, and heat shields
·         In recent years, various initiatives have been undertaken to commercialize CFRP for use in mass production of vehicles. In order to sustain increasing competition, composite suppliers are forced to upgrade their capabilities to cater to higher volume segments
·         In April 2017, Solvay entered into a consortium with Bentley and Penso to develop high-volume composite technologies
·         Countries such as Japan, China, Vietnam, and Indonesia have laid down several policies pertaining to emission control, in keeping with EU’s emission standards
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/automotive-and-transportation
Grand View Research has segmented automotive polymer composites market on the basis of resin, product, application, end use, manufacturing process, and region:
Automotive Polymer Composites Resin Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Epoxy
·         Polyurethane
·         Polyamide
·         Polypropylene
·         Polyethylene
·         Polyester
·         Vinyl Ester
·         Other Resins
Automotive Polymer Composites Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Carbon Fiber
·         Glass Fiber
·         Natural Fiber
Automotive Polymer Composites Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Polyethylene
·         Detergent Alcohol
·         Synthetic Lubricants
·         Others
Automotive Polymer Composites End-use Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Conventional Vehicles
·         Electric Vehicles
·         Trucks & Buses
Automotive Polymer Composites Manufacturing Process Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Compression Molding
·         Injection Molding
·         Sheet Molding
·         Resin Transfer Molding
Automotive Polymer Composites Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    U.K.
o    France
o    Spain
·         Asia Pacific
o    China
o    Japan
o    India
o    Taiwan
·         Middle East and Africa
·         Central & South America
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-automotive-polymer-composites-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



Thursday 1 February 2018

Patient Positioning Systems Market Expected to grow by 2025 due to Increasing Geriatric Population : Grand View Research, Inc.

The global patient positioning systems market is anticipated to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.7% CAGR during the forecast period. This market is expected to witness lucrative growth during through 2025 owing to rising awareness about and surging expenditure on diagnostic procedures. In addition, increasing prevalence of cancer and rising geriatric population are expected to assist in market growth.
According to the National Cancer Institute, in 2016, there were 1,685,210 new cases of cancer diagnosed in U.S. and 14.1 million cases globally. The most common types of cancer are breast cancer, prostate cancer, and colon and rectum cancer. This steady increase in disease prevalence acts as a driver for R&D investments in the industry. Increase in innovation has resulted in improved efficiency and accuracy of these systems in cancer therapy. These products keep patients immobile yet comfortable during radiotherapy. This is anticipated to supplement industry growth.
Rising expenditure on diagnostics procedures has been a strong force driving demand in the market. According to a research published by NCBI, majority oncologists and cardiologists in U.S. and Germany prescribe diagnostics tests and choose a treatment plan only after studying test results. Thus, demand for diagnostics tests is increasing globally.
Full research report on patient positioning systems market analysis: https://www.grandviewresearch.com/industry-analysis/patient-positioning-systems-market

Further key findings from the study suggest:
·         By product, the tables segment held a lucrative market share in 2016, owing to increasing prevalence of cancer and rising number of surgeries performed
·         In terms of application, the surgery segment is expected to account for the dominant market share on account of rising incidence of cancer, globally
·         By end use, the ambulatory segment is expected to register the highest growth over the forecast period owning to increase in precision of minimally invasive technologies
·         North America is projected to dominate the patient positioning systems market over the forecast period due to presence of a large number of diagnostic centers
·         Some of the key players in the patient positioning systems market are Medtronic; Hill-Rom Holdings, Inc.; Stryker Corporation; Medline Industries; Skytron, LLC; OPT SurgiSystems Srl; SchureMed; Smith & Nephew; STERIS plc; and Leoni.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global patient positioning systems market on the basis of products, application, end use, and region:
Patient Positioning Systems Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Tables
·         Accessories
Patient Positioning Systems Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Surgery
·         Diagnostics
·         Other
Patient Positioning Systems End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospital
·         Ambulatory Centers
·         Other
Patient Positioning Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
o    France
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa (MEA)
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


Wednesday 31 January 2018

Radiofrequency Ablation Devices Market Expected To Grow Due To Growing Global geriatric population by 2020 : Grand View Research, Inc.

Global radiofrequencyablation devices market is expected to reach USD 8.85 billion by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of target disorders related to pain such as BPO (benign prostatic obstruction) and osteoporosis pain and growing global geriatric population base is expected to serve this market as high impact rendering drivers. Technology innovation in each product segment in terms of cost effectiveness and user friendliness is also expected to further market demand.
Surgical oncology dominated the overall market in terms of share and was valued at over USD 1 billion in 2013 majorly on account of high procedure volumes and cancer prevalence. However, the radiofrequency ablation devices for hypertension market on account of increasing demand from patients and subsequent increase in R&D initiatives is expected to grow at the fastest CAGR during the forecast period.
Full research report on radiofrequency ablation devices market analysis: http://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market
Further key findings from the study suggest:
·         Global radiofrequency ablation devices market was 19,619.0 thousand units in 2013 and is expected to reach 78,899.1 thousand units by 2020, growing at a CAGR of 22.0% over the next six years.
·         Disposable radiofrequency ablation devices accounted for the largest market share in 2013 and are expected to grow at a CAGR over 20.0% from 2014 to 2020. Increasing government initiatives aimed at curbing post surgery hospital acquired infections and cost effectiveness associated with these products are two factors accounting for its rapid growth.
·         North America, owing to the presence of high healthcare expenditure, sophisticated healthcare infrastructure and increasing prevalence of pain related problems dominated the overall market in terms of revenue in 2013. As per the Community Chiropractic Centre report, over 31.0% of Americans suffer from back pain problems and such large presence of target patients is expected to boost the demand for radiofrequency ablation devices in the region.
·         The Asia Pacific radiofrequency ablation devices market is expected to grow at a CAGR of over 20.0% during the forecast period. Rapidly growing economic conditions and improving healthcare infrastructure in the emerging markets of China and India are expected to present the market with lucrative growth opportunities. Introduction of technological advancements such as multi needle electrode on the grounds of accuracy, portability and cost effectiveness is also expected to serve this market as a driver by catering to changing customer requirements.
·         Some key market players of radiofrequency ablation devices include Stryker Corp., Accuray, St. Jude Medical Inc., Neurotherm Inc., Biosense Webster, Diros Technology Inc., Cosman Medical Inc. and Kimberly-Clark Corporation.
·         The market is marked by the presence of strategic mergers and acquisitions aimed at improving distribution networks, product portfolio and regional presence. For example, Stryker Corporation announced the acquisition of Berchtold Holding AG in April 2014. This initiative is expected to strengthen Stryker Corporation’s presence in the business segment catering to radiofrequency ablation devices based chronic pain management.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global radiofrequency ablation devices market on the basis of product, application and region:
Global Radiofrequency Ablation Devices Product Outlook (Volume, Thousand units; Revenue, USD Million, 2012 - 2020)
·         Capital equipment
o    Radiofrequency ablation generator
·         Reusable equipment
o    Radiofrequency ablation probes
o    Radiofrequency ablation electrodes
·         Disposable equipment
o    Radiofrequency ablation cannulas
o    Radiofrequency ablation needles
o    Radiofrequency ablation single use probes
o    Radiofrequency ablation single use electrodes
Global Radiofrequency Ablation Devices Application Outlook (Volume, Thousand units; Revenue, USD Million, 2012 - 2020)
·         Surgical oncology
·         Cardiology and cardiac rhythm management
·         Pain management
·         Gynecology
·         Hypertension
·         Cosmetology
Radiofrequency Ablation Devices Regional Outlook (Volume, Thousand units; Revenue, USD Million, 2012 - 2020)
·         North America
·         Europe
·         Asia Pacific
·         RoW
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-radiofrequency-ablation-devices-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Nuclear Medicine Market Is Expected To Reach Usd 13.8 Billion By 2024 Due To Growing Wide Use In The Diagnosis: Grand View Research, Inc.

The nuclear medicine market is expected to reach USD 13.8 billion by 2024, according to a new report by Grand View Research, Inc. The burden of chronic diseases such as cancer and cardiac disorders is on rise. Nuclear medicine products are widely used for diagnosis as well as treatment of cancerous and cardiovascular disease.
The increasing prevalence of these disorders poses direct impact on usage of radiopharmaceutical market. For instance, as per the data published by the World Health Organization (WHO), the incidences of cancer are anticipated to increase by 70.0% which is further anticipated to drive the demand for radiopharmaceuticals.
The diagnostics when combined with nuclear medicine improve on accuracy. The accuracy in the diagnosis has a direct impact on the decision-making and treatment monitoring process. Adoption of PET as a diagnostic tool is rapidly increasing since it has high accuracy over other diagnostic techniques.
Full research report on Nuclear Medicine Market analysis: http://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Further key findings from the study suggest:
·         The product segments of nuclear medicine are divided into diagnostic and therapeutic. Diagnostic products held commanding share in 2015, this can be attributed to the advancements in scanning technologies.
·         Therapeutic products such as Alpha Emitters, Beta Emitters and Brachytherapy are anticipated to exhibit lucrative growth.
·         The key diagnostic application areas of nuclear medicine formed the largest market in 2015. These applications are in cardiology, neurology, oncology, and thyroid.
·         North America owing to well-planned policies, reimbursement structure, high healthcare spending and increasing awareness dominated global nuclear medicine market in 2015.
·         Asia Pacific is expected to witness lucrative growth in coming eight years. Increasing per capita income and reform in policies is favoring market players in terms of ease of doing business.
·         The players in the nuclear medicine industry include Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare, Jubilant Life Sciences, Bracco Imaging S.p.A, Nordion, Inc.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global nuclear medicine market on the basis of product and region:
Global Product Outlook (Revenue, USD Million, 2013 - 2024)
·         Diagnostics
o    SPECT
o  TC-99m
o  TL-201
o  GA-67
o  I-123
o  Others
o    PET
o  F-18
o  RB-82
o  Others
·         Therapeutics
o    Alpha Emitters
o  RA-223
o    Beta Emitters
o  I-131
o  Y-90
o  SM-153
o  Re-186
o  Lu-117
o  Others
o    Brachytherapy
o  Cesium-131
o  Iodine-125
o  Palladium-103
o  Iridium-192
o  Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-nuclear-medicines-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com